Eden Research Expands Mevalone® Application to California Grape Market

PUBLISHED: 13 May 2025 @ 08:18 | Comments (0) | More info about Fiona Craig

Eden Research plc (LSE:EDEN) has received approval for its Mevalone® fungicide to be used in controlling powdery mildew in grapes in California, broadening its application beyond the current use for Botrytis cinerea. This approval is particularly significant for the California grape industry, one of the largest in the world. The move enhances the product’s versatility and offers growers in the region an effective, residue-free alternative to traditional fungicides. While this regulatory advancement could boost market share, Eden does not expect any immediate changes to its revenue projections. The approval underscores Eden’s ongoing commitment to sustainable agricultural solutions.

About Eden Research

Eden Research plc is a leader in sustainable biopesticides and biocontrol technologies, focused on providing environmentally friendly solutions to meet the challenges of modern agriculture.

Average Trading Volume: 468,811
Technical Sentiment: Sell
Current Market Capitalization: £14.67 million

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Ltd. ADVFN Ltd does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.